Stay In The Know

Join The Discord & Study Up With The Foundation Video Series https://tradejournal.co/connect

Live Stream

Timestamps in video description

https://youtu.be/a1E3u9A_o0s

News

MorningBrew and other sources

Colorado Shooting

https://www.wsj.com/articles/police-respond-to-active-shooter-at-colorado-supermarket-11616454128?mod=hp_lead_pos5

Covid-19 Live Updates: U.S. Health Officials Question AstraZeneca Vaccine Trial Results

https://www.nytimes.com/live/2021/03/23/world/covid-vaccine-coronavirus-cases

Notes / Research / Recap / Additional Video

Monthly Mentioned Tickers

1. RMGB
   • Indias largest renewable energy company gets SPAC deal
   • Backed by palihapitiya
2. RBLX
   • Roblox Goes Public — What's Roblox? Ask Anyone With Kids
   • $30B roughly

Merch Coupons & Help!

 420 Art is live for Team Winkler on Jeff's website (10% discount code: “AWinkler)

https://www.jeffthe420chef.com/shop?Product+Type=420+Art

Tulip mania art work - (10% Off Code: AlexWinkler)

https://www.annettewinkler.com

Watchlist

99% 14mc 4f

March 23, 2021 05:20 AM ET (BZ Newswire) -- Biotech

The shares of Benitec Biopharma Inc (NASDAQ:BNTC) are trading 92.5% higher at $6.14 in the early pre-market session on Tuesday. 

What Happened: Benitec shares had closed at $3.19 on Monday.

The surge follows Morgan Stanley (NYSE:MS) disclosing in a filing with the U.S. Securities and Exchange Commission after the markets closed on Monday that it had increased its stake by about 5.2% in the Australian biotechnology company.

Morgan Stanley disclosed in the 13G filing it now owned 249,174 shares in Benitec, compared to about 13,100 earlier.

Benitec is engaged in providing gene silencing therapies, combining RNA interference with gene therapy.

The company’s stock has a 52-week high of $17.39 and a 52-week low of $2.3. Benitec remained flat year-to-date as of Monday’s close, having ended 2020 at $3 per share.

110% 58mc 18f

Stonepeak Infrastructure Partners, a leading independent investment firm with a long history of supporting critical North American infrastructure investment, signed a MOU to commit $600 million for the project’s construction equity to launch the project’s multi-billion dollar funding needs

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Northwest Advanced Bio-Fuels, LLC (NWABF), a renewable bio-jet fuel refineries developer, with the recent execution of a Memorandum of Understanding, (“MOU”), has made major progress toward securing a strategic long-term investment into its Sustainable Aviation Fuel (“SAF”) project in Washington State (the “Project”) from Stonepeak Infrastructure Partners (“Stonepeak”), an independent investment firm specializing in North American infrastructure.

The potential $600 million investment from Stonepeak, arranged by Morgan Stanley & Co. LLC as placement agent, may be made through SP Holdings LLC, or another fund or entity managed by Stonepeak. SP Holdings, LLC, is the sole member of the general partner of Evolve Transition Infrastructure LP (NYSE American: SNMP), a publicly-traded limited partnership formed in 2005 focused on the acquisition, development and ownership of infrastructure critical to the transition of energy supply to lower carbon sources. Once finalized, the investment would help finance the largest announced SAF/renewable biofuels project using cellulosic feedstock in the world.

This announcement is a major milestone for the SAF industry and airlines to progress commitments to achieving carbon neutrality and combating climate change in the aviation sector.

The Project has an attractive, long-term 60+ million gallon per year off-take agreement, which is one of the largest airline off-take agreements of its kind to purchase SAF. As originally announced with Delta Air Lines in January 2020, and as affirmed in March 2021, NWABF is a key partner to help Delta achieve zero-impact aviation.

This potential investment would be used to partially fund the construction of the Project and repay prior development, design and engineering stage costs. The Project’s production and supply of 60+ million gallons of sustainable aviation fuel annually is before considering expansion capability.

Funding for this initial NWABF project would support the company’s long-term goal of developing a sector leading sustainable aviation fuel growth platform able to capitalize on further follow-on opportunities in this important and critical energy transition asset class. NWABF is seeking to become a leader in SAF by growing additional projects in the renewable fuels space. The execution of the MOU with Stonepeak validates our team, vision and growth potential as a critical link in the global energy transition to reduce emissions.

“We are excited that a leading infrastructure investment firm sees the potential and the promise of the SAF Industry as well as future potential projects by our team, who have been vital to getting this Project to this point,” said Dave Smoot, Founder and Manager of the Northwest Advanced Bio-Fuels Project. “We have strived to establish a workable platform to use for future opportunities, which the NWABF team will continue to lead.”

Stonepeak has a significant history of investing in high quality, critical infrastructure projects both in the U.S. and globally, with a particular focus on building long-term strategic partnerships. In recent years, Stonepeak has invested significant capital behind the energy transition mega-trend, including in SP Holdings, LLC, the privately held sole member of the general partner of Evolve Transition Infrastructure (NYSE American: SNMP), a publicly-traded limited partnership formed in 2005 focused on the acquisition, development and ownership of infrastructure critical to the transition of energy supply to lower carbon sources, as well as projects across the renewables, lower carbon power generation, and LNG sectors.

60% 26mc 5f

Loads of insider buying around 2.5 in March and at lower prices hte months leading up

AUSTIN, Texas, March 23, 2021 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing novel, targeted therapies for rare and difficult to treat cancers, today announced that it has entered into a master services agreement (MSA) with Piramal Pharma Solutions (PPS) for the development, manufacture, and supply of Plus’ Rhenium NanoLiposome (RNL™) intermediate drug product.

50% 49mc 7f

140% 42mc 5f

Dolphin Entertainment Launches Non-Fungible Tokens (NFTs) Creation and Marketing Division; Expects First Partnership in Collectibles

40% 42mc 9f

Free Gap Scanner + Win 2 Free Stocks 🎉 (Each Up To $1600) 👉👉 http://enzlo.com/webull

Best Savings Account Ever! 😍 Win $10 Million - Use Code: WINKLER 👉👉 http://enzlo.com/save

Watchlist 👉👉 https://tradejournal.co/post/tuesday-pre-market-top-gainers-450/